AAAAAA

   
Results: 1-14 |
Results: 14
Superselective intra-arterial carboplatin for treatment of intracranial neoplasms: experience in 100 procedures
Authors: Qureshi, AI Suri, MFK Khan, J Sharma, M Olson, K Guterman, LR Hopkins, LN
Citation: Ai. Qureshi et al., Superselective intra-arterial carboplatin for treatment of intracranial neoplasms: experience in 100 procedures, J NEURO-ONC, 51(2), 2001, pp. 151-158
Risk factors for subarachnoid hemorrhage
Authors: Qureshi, AI Suri, MFK Yahia, AM Suarez, JI Guterman, LR Hopkins, LN Tamargo, REJ
Citation: Ai. Qureshi et al., Risk factors for subarachnoid hemorrhage, NEUROSURGER, 49(3), 2001, pp. 607-612
Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke
Authors: Qureshi, AI Ali, Z Suri, MFK Kim, SH Shatla, AA Ringer, AJ Lopes, DK Guterman, LR Hopkins, LN
Citation: Ai. Qureshi et al., Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke, NEUROSURGER, 49(1), 2001, pp. 41-48
Open-label phase I clinical study to assess the safety of intravenous eptifibatide in patients undergoing internal carotid artery angioplasty and stent placement
Authors: Qureshi, AI Ali, Z Suri, MFK Kim, SH Fessler, RD Ringer, AJ Guterman, LR Hopkins, LN
Citation: Ai. Qureshi et al., Open-label phase I clinical study to assess the safety of intravenous eptifibatide in patients undergoing internal carotid artery angioplasty and stent placement, NEUROSURGER, 48(5), 2001, pp. 998-1004
Quantitative analysis of injured, necrotic, and apoptotic cells in a new experimental model of intracerebral hemorrhage
Authors: Qureshi, AI Ling, GSF Khan, J Suri, MFK Miskolczi, L Guterman, LR Hopkins, LN
Citation: Ai. Qureshi et al., Quantitative analysis of injured, necrotic, and apoptotic cells in a new experimental model of intracerebral hemorrhage, CRIT CARE M, 29(1), 2001, pp. 152-157
Frequency and predictors for angiographically improved inflow of contrast medium after carotid angioplasty and stenting
Authors: Luft, AR Qureshi, AI Suri, MFK Janardhan, V Guterman, LR Hopkins, LN
Citation: Ar. Luft et al., Frequency and predictors for angiographically improved inflow of contrast medium after carotid angioplasty and stenting, NEURORADIOL, 43(10), 2001, pp. 877-883
Endovascular treatment of intracranial aneurysms by using Guglielmi detachable coils in awake patients: safety and feasibility
Authors: Qureshi, AI Suri, MFK Khan, J Kim, SH Fessler, RD Ringer, AJ Guterman, LR Hopkins, LN
Citation: Ai. Qureshi et al., Endovascular treatment of intracranial aneurysms by using Guglielmi detachable coils in awake patients: safety and feasibility, J NEUROSURG, 94(6), 2001, pp. 880-885
Cocaine use and the likelihood of nonfatal myocardial infarction and stroke - Data from the Third National Health and Nutrition Examination survey
Authors: Qureshi, AI Suri, MFK Guterman, LR Hopkins, LN
Citation: Ai. Qureshi et al., Cocaine use and the likelihood of nonfatal myocardial infarction and stroke - Data from the Third National Health and Nutrition Examination survey, CIRCULATION, 103(4), 2001, pp. 502-506
Ineffective secondary prevention in survivors of cardiovascular events in the US population - Report from the Third National Health and Nutrition Examination Survey
Authors: Qureshi, AI Suri, MFK Guterman, LR Hopkins, LN
Citation: Ai. Qureshi et al., Ineffective secondary prevention in survivors of cardiovascular events in the US population - Report from the Third National Health and Nutrition Examination Survey, ARCH IN MED, 161(13), 2001, pp. 1621-1628
Acute interventions for ischemic stroke: Present status and future directions
Authors: Qureshi, AI Ringer, AJ Suri, MFK Guterman, LR Hopkins, LN
Citation: Ai. Qureshi et al., Acute interventions for ischemic stroke: Present status and future directions, J ENDOVAS T, 7(5), 2000, pp. 423-428
Intraarterial recombinant tissue plasminogen activator for ischemic stroke: An accelerating dosing regimen
Authors: Qureshi, AI Suri, MFK Shatla, AA Ringer, AJ Fessler, RD Ali, Z Guterman, LR Hopkins, LN
Citation: Ai. Qureshi et al., Intraarterial recombinant tissue plasminogen activator for ischemic stroke: An accelerating dosing regimen, NEUROSURGER, 47(2), 2000, pp. 473-476
Abciximab as an adjunct to high-risk carotid or vertebrobasilar angioplasty: Preliminary experience
Authors: Qureshi, AI Suri, MFK Khan, J Fessler, RD Guterman, LR Hopkins, LN
Citation: Ai. Qureshi et al., Abciximab as an adjunct to high-risk carotid or vertebrobasilar angioplasty: Preliminary experience, NEUROSURGER, 46(6), 2000, pp. 1316-1324
Factors associated with aneurysm size in patients with subarachnoid hemorrhage: Effect of smoking and aneurysm location
Authors: Qureshi, AI Sung, GY Suri, MFK Straw, RN Guterman, LR Hopkins, LN
Citation: Ai. Qureshi et al., Factors associated with aneurysm size in patients with subarachnoid hemorrhage: Effect of smoking and aneurysm location, NEUROSURGER, 46(1), 2000, pp. 44-50
Identification of patients at risk for periprocedural neurological deficits associated with carotid angioplasty and stenting
Authors: Qureshi, AI Luft, AR Janardhan, V Suri, MFK Sharma, M Lanzino, G Wakhloo, AK Guterman, LR Hopkins, LN
Citation: Ai. Qureshi et al., Identification of patients at risk for periprocedural neurological deficits associated with carotid angioplasty and stenting, STROKE, 31(2), 2000, pp. 376-382
Risultati: 1-14 |